ARS Pharmaceuticals, Inc. (SPRY)
8.615
-0.12
(-1.43%)
USD |
NASDAQ |
May 11, 16:00
8.615
0.00 (0.00%)
After-Hours: 19:46
ARS Pharmaceuticals Total Liabilities (Quarterly) : 213.39M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 651.71M |
| Heron Therapeutics, Inc. | 656.54M |
| Krystal Biotech, Inc. | 120.24M |
| Century Therapeutics, Inc. | 64.77M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 327.65M |
| Shareholders Equity (Quarterly) | 114.26M |
| Debt to Equity Ratio | 0.8486 |
| Current Ratio | 7.278 |
| Net Debt Paydown Yield | -1.67% |